• News Highlights

    News about and goings on at FUSION GENOMICS:

  • Season’s Greetings


    As we celebrate this holiday season we thought we’d take a moment to tell you about some of the wonderful things that FUSION GENOMICS accomplished in 2016 and what we’d like to see happen in 2017.

    As you know, FUSION’s mission is to develop simple-to-use molecular diagnostics for infectious disease pathogens that are responsible for major global health problems. In doing so, we aim to establish new paradigms for how diseases are surveyed, monitored and treated in the hopes of preventing future epi- and pandemics and saving lives.

    First and foremost, we now have 3 ONETest assay kits that are market ready and available for purchase, ONETest Influenza Sentinel, ONETest Influenza EnviroScreen, and ONETest Hepatitis. We also further developed and optimized our FUSIONCloud online bioinformatics data analysis platform and it is now ready to analyze the sequencing data from all our ONETest kits and rapidly deliver the answers our clients are seeking.

    FUSION GENOMICS also had several important presentations this past year. We were proud to have a poster of our ONETest Influenza Sentinel showcased at the Options IX for the Control of Influenza annual conference in Chicago this year (Embedding next generation sequencing in influenza surveillance and influenza vaccine effectiveness studies, season 2015/2016, the Netherlands, by Meijer A, de Lange M, Donker G, Overduin P.).

    In August, a scientist from BC presented a paper at the 65th International conference of the Wildlife Disease Association in Cortland, NY (Genomic analysis of wetland sediment as a tool for avian influenza surveillance and prevention) which used our ONETest Influenza EnviroScreen to identify bird flu in wetlands and small water bodies on infected farms.

    FUSION’s CEO, Mohammad Qadir also gave a talk, (ONETest Molecular Diagnostics for Infectious Diseases) in Toronto at the Tenth National Microbiology Diagnostics Users Group Fall Meeting and Annual Conference 2016 which generated a lot of excitement in our approach, products and FUSIONCloud.

    January 9-12, FUSION will be at the JP Morgan Annual Healthcare Conference to be held in San Francisco, 2017.

    January 14-18, FUSION will also be in San Diego at the International Plant & Animal Genome XXV Conference. January will be a busy month for us!

    FUSION was also pleased to be able to expand both our Bioinformatics and Laboratory Teams with 2 new employees each.

    Happy Holidays and New Year to all our friends and wishing you a great 2017!

  • Fusion Breaks into the Product Shows Circuit!

    FUSION GENOMICS makes its first appearance at a product trade show, OPTIONS IX for THE CONTROL OF INFLUENZA, held in Chicago from 24-28 August.

    The products we showcased were our ONETest Influenza Sentinel, our ONETest Influenza EnviroScreen and our FUSION Cloud. It was a lot of work, fun, and a great learning experience for us with many excellent contacts made for future sales and endeavors.

  • Fusion’s Bird Flu Test Generates Excitement!

    At a presentation given by Dr. Chelsea Himsworth at the WILDLIFE DISEASE ASSOCIATION’s ​​​​65TH ANNUAL INTERNATIONAL CONFERENCE on August 5th, Dr. Himsworth showed that Fusion’s ONETest™ Influenza Enviroscreen* clearly outperformed PCR in tests analysing wetland waterfowl sediments for the presence of bird flu virus.

    Wild waterfowl are an important host vectors for transmitting the bird flu strains that infect the poultry industry. If we can detect, identify and track the strains that are present in wetlands adjacent to or near poultry producing facilities, there is a greater chance of preventing costly outbreaks in birds being raised for market.

    Wetland sediment sample to be processed for influenza typing

    Wetland sediment sample

    Our ONETest™ Influenza Enviroscreen is the only test that reliably and accurately detects the influenza virus in wetland sediments and it also identifies viral genotypes and subtypes which could give poultry producers much needed additional time and information to protect their stocks from infection.

    *For Research Use Only

  • Fusion Invited to Compute Canada $14M Award Celebration

    FUSION GENOMICS President and CSO, Mohammmed Qadir was part of the Compute Canada team that celebrated the BC government’s award of $14M to Compute Canada to help fund wide ranging research that benefits Canadians.


    Also present were Dugan O’Neill, Professor of Physics at SFU and CSO at Compute Canada, MLA for Vancouver-False Creek, Sam Sullivan, SFU President Andrew Petter and BC Minister of Technology, Innovation & Citizen Services, Amrik Virk.

  • Fusion is Expanding!

    Fusion is growing and has hired several new employees over the past couple of months! First, the two newest members of our Laboratory Team.

    Sepidah head shotPlease welcome Dr Sepideh Alamouti, the laboratory’s new Program Leader. She will be heading up our efforts to develop several new ONETest™assays for infectious diseases.

    Dan cropDan Fornika, our new Senior Associate and Project Leader will be involved in assay development and optimization. He will also be working on analysis and pipeline progress.

    XiaoFei XiaoFei Zhao is our newest member of the Informatics Team. XiaoFei is working on back-end development of algorithms for analysing ONETest™assays.

  • FUSION Invited to illumina’s 1st Genomics Forum

    On December 9th, illumina’s Accelerator division held it’s 1st ever Genomics Forum to connect interested investors with companies that are at the forefront of genomic technology.

    The Accelerator has been put together by illumina to help entrepreneurs launch their startups in genomics and move the companies forward.

    We are pleased and proud to report that FUSION GENOMICS was 1 of only 17 companies that illumina invited to showcase at this premier event!

    Over the course of the day, Fusion’s Chief Scientific Officer, Mohammed Qadir, and Chief Financial Officer, Akmal Jameer, met one-on-one with several key investors.

    Many thanks to illumina for inviting us to their Genomics Forum.

  • Welcome to Fatemah!

    FUSION GENOMICS is happy to welcome Fatemeh Abedi Samakoush, MSc, the newest member of our team. She is nearing the completion of her second MSc degree, in Cell and Molecular Biology in Dr. Jim Mattsson’s lab at Simon Fraser University, and is working collaboratively with us to learn cutting edge Next Generation Sequencing techniques.

    Fatemah received her BSc degree in Agronomy and Plant Breeding (2007), and a MSc degree in Plant Biotechnology (2010), in Iran which resulted in two publications.

    Fatemah has extensive laboratory experience and has also taught and mentored college students.

    Please give a warm welcome to Fatemah!

  • Welcome to Josh!

    FUSION GENOMICS is happy to welcome Josh Venaccio to our computational biology team. Josh has experience in computer science, programming, data mining and beer brewing. Josh first connected with FUSION’s Brian Kwok and Mohammad Qadir when he was in Advanced Therapeutics at the BC Cancer Agency.

    Josh’s works at relaying information and results between the lab and the bioinformatics team.

    Please give a warm welcome to Josh!

  • Fusion Invited to Illumina’s Genomic Startups Forum!!

    FUSION GENOMICS is pleased to be invited to the Illumina Genomics Startup Forum to be hosted by the Illumina Accelerator on 8-9 December 2015 in the Mission Bay area of San Francisco. This event is by invitation only and brings together select genomic startups and VCs.

    “The Genomics Startup Forum is tailored to the entrepreneurial genomics community and focused on building connections, strengthening community, and advancing novel applications by bringing together genomic startups, investors, and entrepreneurs from healthcare and tech. Through this forum, we aim to inspire the creation, funding, and growth of genomics startups. The event is hosted by Illumina Accelerator and will include approximately 100 attendees from the early and late stage companies, venture investors, and serial entrepreneurs.

    Our outstanding panel of speakers will provide insight and vision for the genomics industry. Topics covered include raising capital, building sustainable competitive advantage, as well as creating successful teams.”

    Speakers Include:

    Bill Banyai, PhD – COO, Twist Bioscience
    Atul Butte, MD, PhD – Director, UCSF Institute for Computational Health Science
    Helmy Eltoukhy, PhD – CEO, Guardant Health
    Shahin Farshchi, PhD – Partner, Lux Capitals
    Elad Gil, PhD – CEO and Co-Founder, Color Genomics
    Simba Gill, PhD – CEO, Evelo Therapeutics
    John Hamer, PhD – Investment Director, Monsanto Ventures
    Brian Kaufmann – Portfolio Manager, Viking Global Investors
    Steve Quake, PhD – Professor, Stanford University
    Chad Robins – President, CEO, and Founder, Adaptive Biotechnologies Corporation
    Mostafa Ronaghi, PhD – SVP & CTO, Illumina, Inc.

    Follow us on twitter to hear the latest developments.

  • Compute Canada Spotlights Fusion!

    Co-founder, Dr Poul Sorenson

    Compute Canada Spotlighted us in a recent report.

    “…FUSION GENOMICS is a Canadian company that was able to transform its discovery research into a commercial interest. With access to powerful computing resources supported by Compute Canada and WestGrid, a Simon Fraser University-based research lab gained access to commercialize products that are available in the marketplace today…”

    Follow us on twitter to hear the latest developments.

  • Page 1 of 2